Event Details
Dates: January 23 - 25, 2026
Location: Fontainebleau Miami Beach, 4441 Collins Ave, Miami Beach, FL 33140, United States
Event Website: https://www.gotoper.com/courses/winter-lung-cancer-conference
Event Overview
Cizzle Bio will attend the 23rd Annual Winter Lung Cancer Conference, a leading educational symposium that brings together clinicians, researchers, and oncology professionals focused on the latest advances in lung cancer management, diagnostics, and translational science. This conference provides an interactive, case-based curriculum featuring expert faculty and sessions designed to tackle key clinical challenges and emerging strategies in lung cancer care.
The program spans evidence-based discussions including lung cancer screening, perioperative strategies, immunotherapy, targeted agents (including KRAS, MET, RET, HER2, and EGFR), tumor boards, and expert Q&A sessions that offer practical insights for clinical application.
Why Attend
Gain access to state-of-the-art clinical content and case-based learning across the lung cancer continuum.
Engage with leading experts and multidisciplinary clinicians in thoracic oncology.
Learn about emerging diagnostics, biomarker testing, and advanced therapeutic approaches that align with Cizzle Bio’s focus on early detection and biomarker innovation.
Participate in both in-person sessions at Fontainebleau Miami Beach and structured discussion formats that encourage real-world clinical decision-making.
Cizzle Bio’s Focus
As a company committed to advancing early cancer detection and cutting-edge diagnostic technologies, Cizzle Bio values the insights shared at the Winter Lung Cancer Conference.
Attendance supports our mission to remain at the forefront of lung cancer research and biomarkers while fostering collaboration with the broader oncology community to improve patient outcomes.